Jonathan Mcneill
President and COO · 1 filing · Latest: Jun 22, 2026
CRESCENT BIOPHARMA, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CBIO | Jonathan Mcneill | President and COO | Jun 22, 2026 | Sale | $17.99 | 20,549 | $369.7K | 139,158 | |
DYN | McNeill Jonathan | — | Nov 25, 2024 | Proposed Sale | $29.69 | 19,987 | $593.4K | — | |
DYN | McNeill Jonathan | — | Nov 18, 2024 | Proposed Sale | $28.39 | 2,658 | $75.5K | — | |
DYN | McNeill Jonathan | — | Sep 18, 2024 | Proposed Sale | $34.51 | 1,870 | $64.5K | — | |
DYN | McNeill Jonathan | — | Sep 11, 2024 | Proposed Sale | $32.43 | 1,823 | $59.1K | — | |
DYN | McNeill Jonathan | — | Sep 5, 2024 | Proposed Sale | $33.61 | 166,767 | $5.6M | — |